19 June 2024
Latham & Watkins Advises Boston Scientific in US$1.16 Billion Acquisition of Silk Road Medical
Advising firms
Deal team
21 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Julie Scallen Lead | Latham & Watkins LLP | Partner | M&A | Boston |
| Ian Nussbaum Lead | Latham & Watkins LLP | Partner | M&A | New York |
| Shannon Cheng | Latham & Watkins LLP | Associate | M&A | Not stated |
| Kennedy Holmes | Latham & Watkins LLP | Associate | M&A | Not stated |
| Amy Lutfi | Latham & Watkins LLP | Associate | M&A | Not stated |
| Rose Kenyon | Latham & Watkins LLP | Associate | M&A | Not stated |
| Ivana Valdez | Latham & Watkins LLP | Associate | M&A | Not stated |
| Ashley Campfield | Latham & Watkins LLP | Associate | M&A | Not stated |
| Oliver Mobasser | Latham & Watkins LLP | Associate | intellectual property and licensing | Not stated |
| Josh Friedman | Latham & Watkins LLP | Partner | benefits and compensation | Boston |
| Rebecca Fishbein | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Tessa Young | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Nicholas DeNovio | Latham & Watkins LLP | Partner | tax | Washington, D.C. |
| Abigail Friedman | Latham & Watkins LLP | Associate | tax | Not stated |
| Nolon Blaylock | Latham & Watkins LLP | Associate | tax | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | life sciences regulatory | Bay Area |
| Elizabeth Richards | Latham & Watkins LLP | Partner | life sciences regulatory | Washington, D.C. |
| Leia Gu | Latham & Watkins LLP | Associate | life sciences regulatory | Not stated |
| Evan Miller | Latham & Watkins LLP | Associate | life sciences regulatory | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Mitch Bennett | Latham & Watkins LLP | Associate | data privacy | Not stated |
18 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 1.16bn (US$1.16 billion)
- What the figure measures
- Enterprise value
- Client
- Boston Scientific CorporationBuy-side
- Counterparties
- Silk Road Medical, Inc. (Sell-side)